CD274 and neoplasm: Moreover, when anti-PD-L1 antibody (aPD-L1) is combined with these nanocomposites, aPD-L1 + PDT + PTT may increase infiltration of CTLs and suppress myeloid-derived suppressor cells (MDSCs) as well as polarize MDSCs toward the M1 phenotype in tumor sites [132].